These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32573235)

  • 1. Dually Enzyme- and Acid-Triggered Self-Immolative Ketal Glycoside Nanoparticles for Effective Cancer Prodrug Monotherapy.
    Yu N; Liu T; Zhang X; Gong N; Ji T; Chen J; Liang XJ; Kohane DS; Guo S
    Nano Lett; 2020 Jul; 20(7):5465-5472. PubMed ID: 32573235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid-sensitive PEGylated paclitaxel prodrug nanoparticles for cancer therapy: Effect of PEG length on antitumor efficacy.
    Mu J; Zhong H; Zou H; Liu T; Yu N; Zhang X; Xu Z; Chen Z; Guo S
    J Control Release; 2020 Oct; 326():265-275. PubMed ID: 32687940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modular Acid-Activatable Acetone-Based Ketal-Linked Nanomedicine by Dexamethasone Prodrugs for Enhanced Anti-Rheumatoid Arthritis with Low Side Effects.
    Xu Y; Mu J; Xu Z; Zhong H; Chen Z; Ni Q; Liang XJ; Guo S
    Nano Lett; 2020 Apr; 20(4):2558-2568. PubMed ID: 32167768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-penetrating iRGD facilitates penetration of poly(floxuridine-ketal)-based nanomedicine for enhanced pancreatic cancer therapy.
    Li X; Zhong H; Zheng S; Mu J; Yu N; Guo S
    J Control Release; 2024 May; 369():444-457. PubMed ID: 38575076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique highly hydrophobic anticancer prodrug self-assembled nanomedicine for cancer therapy.
    Ren G; Jiang M; Xue P; Wang J; Wang Y; Chen B; He Z
    Nanomedicine; 2016 Nov; 12(8):2273-2282. PubMed ID: 27389147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembling nanoparticles of dually hydrophobic prodrugs constructed from camptothecin analogue for cancer therapy.
    Zhang Y; Yin R; Wu G; Yu M; Liu J; Wang X; Liu X; Guan H; Yu R; Jiang T
    Eur J Med Chem; 2020 Aug; 200():112365. PubMed ID: 32460113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimuli-responsive prodrug-based cancer nanomedicine.
    Xie A; Hanif S; Ouyang J; Tang Z; Kong N; Kim NY; Qi B; Patel D; Shi B; Tao W
    EBioMedicine; 2020 Jun; 56():102821. PubMed ID: 32505922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
    Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ
    J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cascade-amplified self-immolative polymeric prodrug for cancer therapy by disrupting redox homeostasis.
    Dey A; Jeon J; Yoon B; Li Y; Park JH
    J Control Release; 2023 Jun; 358():555-565. PubMed ID: 37182804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W; Xi M; Duan X; Wang Y; Kong F
    Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy.
    Huang Z; Ding Y; Luo Y; Chen M; Zeng Z; Zhang T; Sun Y; Huang Y; Zhao C
    Acta Biomater; 2022 Oct; 152():367-379. PubMed ID: 36084924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistry.
    Gopin A; Ebner S; Attali B; Shabat D
    Bioconjug Chem; 2006; 17(6):1432-40. PubMed ID: 17105221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimerization-induced self-assembly of a redox-responsive prodrug into nanoparticles for improved therapeutic index.
    Zhou L; Xie H; Chen X; Wan J; Xu S; Han Y; Chen D; Qiao Y; Zhou L; Zheng S; Wang H
    Acta Biomater; 2020 Sep; 113():464-477. PubMed ID: 32652227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox-Sensitive Hyaluronic Acid Polymer Prodrug Nanoparticles for Enhancing Intracellular Drug Self-Delivery and Targeted Cancer Therapy.
    Lu B; Xiao F; Wang Z; Wang B; Pan Z; Zhao W; Zhu Z; Zhang J
    ACS Biomater Sci Eng; 2020 Jul; 6(7):4106-4115. PubMed ID: 33463311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives.
    Roemhild K; Besse HC; Wang B; Peña Q; Sun Q; Omata D; Ozbakir B; Bos C; Scheeren HW; Storm G; Metselaar JM; Yu H; Knüchel-Clarke R; Kiessling F; Moonen CTW; Deckers R; Shi Y; Lammers T
    Theranostics; 2022; 12(10):4791-4801. PubMed ID: 35832083
    [No Abstract]   [Full Text] [Related]  

  • 18. Nanoassemblies of Self-Immolative Boronate-Bridged Retinoic Acid Dimeric Prodrug as a Clot-Targeted Self-Deliverable Antithrombotic Nanomedicine.
    Jun H; Jeon C; Kim S; Song N; Jo H; Yang M; Lee D
    ACS Nano; 2023 Jul; 17(13):12336-12346. PubMed ID: 37382227
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative and high drug loading of self-assembled prodrug with defined molecular structures for effective cancer therapy.
    Tang J; Zeng Z; Yan J; Chen C; Liu J; Feng X
    J Control Release; 2019 Aug; 307():90-97. PubMed ID: 31185233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymersome nanoreactors with tumor pH-triggered selective membrane permeability for prodrug delivery, activation, and combined oxidation-chemotherapy.
    Mukerabigwi JF; Yin W; Zha Z; Ke W; Wang Y; Chen W; Japir AAMM; Wang Y; Ge Z
    J Control Release; 2019 Jun; 303():209-222. PubMed ID: 31026547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.